CURE Pharmaceutical Launches New Academic Partnership Program Providing the Company’s Proprietary CureFilm™ for More Humane and Effective Animal Research
September 06, 2017 09:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., Sept. 06, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company, today announced the launch of a new academic...
Leading OTF Manufacturer CURE Pharmaceutical Comments on New Report Showing Exponential Growth in Thin Film Drug Manufacturing Market
June 07, 2017 11:13 ET
|
CURE Pharmaceutical
OXNARD, Calif., June 07, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development...
FUISZ Announces Filing of Patent Application Relating to New Manufacturing Methods and Compositions for Oral Soluble Films, Superior to Wet Casting Methodologies (Amended Press Release)
April 17, 2017 08:45 ET
|
Fuisz Pharma LLC
Bethlehem, PA, April 17, 2017 (GLOBE NEWSWIRE) -- Fuisz today announced the filing of a patent application with the United States Patent & Trademark Office relating to new methods of manufacture...
FUISZ Announces Filing of Patent Application Relating to New Manufacturing Methods and Compositions for Oral Soluble Films, Superior to Wet Casting Methodologies
April 17, 2017 07:30 ET
|
Fuisz Pharma LLC
Bethlehem, PA, April 17, 2017 (GLOBE NEWSWIRE) -- Fuisz today announced the filing of a patent application with the United States Patent & Trademark Office relating to new methods of...